Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective ATRA plus chemotherapy for acute promyelocytic leukemia
DRKS00004314Phase 3Active, not recruiting
- Sponsor
- Universitätsklinikum Münster
- Start
- Aug 2012
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of tretinoin, daunorubicin, cytarabine, mitoxantrone, tioguanine and 1 more in Acute promyelocytic leukaemia (APL), sponsored by Universitätsklinikum Münster. Started Aug 2012; status: active, not recruiting.
02
Drugs
tretinoindaunorubicincytarabinemitoxantronetioguanine
03
Conditions
Acute promyelocytic leukaemia (APL)
Beyond the preview
Go deeper on DRKS00004314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00004314.